Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310


Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Hanamura A, Cáceres JF, Mayeda A, Franza BR Jr, Krainer AR.

RNA. 1998 Apr;4(4):430-44.


Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Mayeda A, Helfman DM, Krainer AR.

Mol Cell Biol. 1993 May;13(5):2993-3001. Erratum in: Mol Cell Biol 1993 Jul;13(7):4458.


Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.

Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM.

Mol Carcinog. 2004 Dec;41(4):187-96.


Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

Pilch B, Allemand E, Facompré M, Bailly C, Riou JF, Soret J, Tazi J.

Cancer Res. 2001 Sep 15;61(18):6876-84.


hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.

Expert-Bezançon A, Sureau A, Durosay P, Salesse R, Groeneveld H, Lecaer JP, Marie J.

J Biol Chem. 2004 Sep 10;279(37):38249-59. Epub 2004 Jun 18.


Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Cáceres JF, Stamm S, Helfman DM, Krainer AR.

Science. 1994 Sep 16;265(5179):1706-9.


Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.

Rooke N, Markovtsov V, Cagavi E, Black DL.

Mol Cell Biol. 2003 Mar;23(6):1874-84.


Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Mayeda A, Krainer AR.

Cell. 1992 Jan 24;68(2):365-75.


HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.

Guo R, Li Y, Ning J, Sun D, Lin L, Liu X.

PLoS One. 2013 Apr 29;8(4):e62729. doi: 10.1371/journal.pone.0062729. Print 2013.


Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.

Eperon IC, Makarova OV, Mayeda A, Munroe SH, Cáceres JF, Hayward DG, Krainer AR.

Mol Cell Biol. 2000 Nov;20(22):8303-18.


The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Petersen-Mahrt SK, Estmer C, Ohrmalm C, Matthews DA, Russell WC, Akusjärvi G.

EMBO J. 1999 Feb 15;18(4):1014-24.


Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.

Ropers D, Ayadi L, Gattoni R, Jacquenet S, Damier L, Branlant C, Stévenin J.

J Biol Chem. 2004 Jul 16;279(29):29963-73. Epub 2004 Apr 27.


Differential ASF/SF2 activity in extracts from normal WI38 and transformed WI38VA13 cells.

Chabot B, Frappier D, La Branche H.

Nucleic Acids Res. 1992 Oct 11;20(19):5197-204.


The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Tange TO, Damgaard CK, Guth S, Valcárcel J, Kjems J.

EMBO J. 2001 Oct 15;20(20):5748-58.

Items per page

Supplemental Content

Write to the Help Desk